Pfizer Launches Lyrica Nine Months After First Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
Pregabalin gestational period encompassed approval of three indications, DEA scheduling and production of packaging.
You may also be interested in...
FDA Controlled Substances Staff To Focus On Early Engagement With Sponsors
The new director of FDA's Controlled Substance Drug Staff, Michael Klein, wants to help sponsors find the optimal time to work with the agency on potential abuse issues surrounding their products
FDA Controlled Substances Staff To Focus On Early Engagement With Sponsors
The new director of FDA's Controlled Substance Drug Staff, Michael Klein, wants to help sponsors find the optimal time to work with the agency on potential abuse issues surrounding their products
Depomed Starts Gabapentin Extended Release Pivotal Trial
Pain product would have dosing advantage over Pfizer's Lyrica.